OncoTherapy Science, Inc.
オンコセラピー・サイエンス株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4564
FY2025 · 2026-03-31
| Gross margin | 1.7% |
| Operating margin | -100.2% |
| Net margin | -112.6% |
| Return on equity | -44.0% |
| Return on assets | -38.6% |
| Revenue growth (YoY) | 7.8% |
| EPS (basic) | ¥-2.77 |
| EPS growth (YoY) | — |
| Current ratio | 13.59x |
| Equity ratio | 87.8% |
| Book value / share | ¥5.4 |
| Free cash flow | -985 M |